阿考替胺有哪几个版本?分别多少钱?

Acotiamide is a new digestive system drug developed by Japan's Zeria and jointly developed with Astellas. Its version selection, price differences and market access have an important impact on patients' medication decisions. Understanding the features, price levels, and domestic availability of different versions can help patients develop a reasonable treatment plan. This article will introduce these three key aspects in detail.

What are the versions of acotiamide?

There are mainly two versions globally, which are developed to meet the market needs of different regions. There are certain differences in specifications and packaging.

Japanese original version

The original version developed by Japanese pharmaceutical companies, the main specifications are 100mg*100 tablets. This version is sold in the domestic market of Japan, with Japanese packaging and instructions.

International authorized version

A version produced through technical licensing in some Asian countries. The common specification is 100mg*60 tablets. Such versions are usually labeled in local languages, and excipient recipes may be adjusted based on regional needs.

The two versions are consistent in active ingredients and basic efficacy, but there are differences in packaging specifications and auxiliary materials. Patients can choose the appropriate version according to actual needs.

How much do different versions of acotiamide cost?

The price of acotiamide is affected by multiple factors such as production area, size and sales channels, and shows obvious regional differences.

Japanese market price

The price of acotiamide in the Japanese market is relatively stable. The price of 100mg*100 tablets is about US$50. This price includes consumption tax and is basically the same in all major regular pharmacies.

Price in other regions

The price of the international version produced through authorization is slightly higher, and the price of 100mg*60 tablets is about US$40-45. In some areas, due to import tariffs and other factors, the price may reach more than 60 US dollars.

Price differences are mainly due to transportation costs, tariff policies and local drug pricing mechanisms. When purchasing, you should choose formal channels to avoid purchasing counterfeit products due to the desire for low prices.

The marketing and medical insurance status of acotiamide in China

Acotiamide has not yet received formal marketing approval in China, and is not covered by medical insurance reimbursement. Domestic patients have certain difficulties in obtaining the drug.

Domestic approval status

As of May 2025, the China National Medical Products Administration has not approved acotiamide for domestic marketing, and clinical use requires special approval procedures or overseas legal channels to purchase.

Suggestions on how to obtain it

Patients in need can obtain it through the following methods: participating in clinical trial projects, applying for special import through designated medical institutions, or legally purchasing it from countries where it has been listed and declaring it according to law.

When it is not officially launched in China, patients should carefully choose the acquisition channel, ensure the quality of the drug, and use it under the guidance of professional doctors.